Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Czech Republic: Stimvia appoints Russ Mably as CEO to accelerate global growth

Life Sciences Nick Herbert -
Stimvia, a Czech Republic-based neuromodulation company focused on transforming the treatment of bladder dysfunction, has appointed Russ Mably as CEO. Mably will lead the company through its next phase of international growth, expanding access to the firm’s personalised neuromodulation platform and advancing its mission to improve outcomes for patients...

UK: Duke Street sells Kent-Athlone Pharma Group to Phoenix Labs

Consumer Healthcare Nick Herbert -
European mid-market investor, Duke Street, has sold specialty pharma group, Kent Pharmaceuticals, to Phoenix Labs, an integrated healthcare company operating in the prescription and OTC market segments, with two manufacturing sites across UK & Ireland. The acquisition will expand Phoenix’s operations in the UK and provide synergies across the product portfolio and geographies. Financial terms have not been disclosed. Kent Pharma is a UK-headquartered distributor of specialty and generic pharmaceuticals in the UK and Ireland. An important partner to the NHS, it is a one of the top suppliers of injectables...